FMP
Perspective Therapeutics, Inc.
CATX
NYSE
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
12.39 USD
-0.31 (-2.5%)
About
ceo
Mr. Johan M. Spoor
sector
Healthcare
industry
Medical - Devices
exchange
NYSE
Description
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is b...
CIK
0000728387
ISIN
US46489V1044
CUSIP
N/A
Address
350 Hills Street
Phone
509 375 1202
Country
US
Employee
116
IPO Date
Nov 10, 2005
CATX Financial Summary
CIK
0000728387
Exchange
NYSE
Industry
Medical - Devices
Sector
Healthcare
CUSIP
-
ISIN
US46489V1044
Country
US
Price
12.39
Beta
1.44
Volume Avg.
878.41k
Market Cap
835.43M
Shares
-
52-Week
2.2-19.1
DCF
-0.24
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-8.43
P/B
-
Website
https://www.perspectivetherapeutics.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CATX News
It looks like there's no news available.
